FDA-Drug2025-01-01Class II
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
MXBBB
Hazard
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
Sold states
Product was sold via Amazon Marketplace.
Affected count
321 bottles
Manufactured in
1162 Tio Dink Cir, El Paso, TX, United States
Products
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0166-2025Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief